The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis-Reference-Cited by-同舟云学术

The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis

Published:2022-02-22 Issue:5 Volume:31 Page:577-582
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiology and Drug

Author:

Althunian Turki A.¹^ORCID,Alomran Maha I.¹,Alsagri Ghada M.¹,Alrasheed Meshael M.¹,Alshammari Thamir M.¹²

Affiliation:

1. Executive Directorate for Research and Studies Saudi Food and Drug Authority Riyadh Saudi Arabia

2. College of Pharmacy Riyadh Elm University Riyadh Saudi Arabia

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5408

Reference33 articles.

1. Saudi Food and Drug AuthorityDrug list: Lyrica 25; Reg No. 25‐211‐06.https://sfda.gov.sa/ar/drugs-list(Accessed February 2021).

2. National Institute for Health and Care ExcellenceNeuropathic pain in adults: pharmacological management in non‐specialist settings. 2013.https://www.nice.org.uk/guidance/cg173/resources/neuropathic‐pain‐in‐adults‐pharmacological‐management‐in‐nonspecialist‐settings‐pdf‐35109750554053(Accessed February 2021).

3. European Medicines AgencyLyrica (Pregabalin). 2005.https://www.ema.europa.eu/en/medicines/human/EPAR/lyrica(Accessed February 2021).

4. U.S. National Library of MedicineDailyMed. Lyrica‐pregabalin 75mg capsule. 2021.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afc8c76e-9b21-7ddb-e053-2a95a90ad736(Accessed February 2021).

5. Therapeutic Goods AdministrationAustralian product information. Lyrica ® (Pregabalin). 2021.https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-04219-3&d=202102241016933(Accessed February 2021).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Community pharmacists’ experience of gabapentin misuse and abuse: A quantitative study from Jordan;Journal of Ethnicity in Substance Abuse;2024-07-05

2. The impact of a restricted pregabalin prescription policy on drug utilization: An observational multicenter study;Saudi Pharmaceutical Journal;2023-12

3. Trends in anti-neuropathic medications turnover in Iraq;Journal of Pharmaceutical Health Services Research;2023-10-25

4. Suspected inappropriate use of prescription and non-prescription drugs among requesting customers: A Saudi community pharmacists’ perspective;Saudi Pharmaceutical Journal;2023-07

5. Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study;International Journal of General Medicine;2023-04